Trials / Completed
CompletedNCT01647646
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma: Symbicort SMART, or Other ICS/LABA With as Needed SABA
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Far Eastern Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In real life, the investigators will be using different strategies including SMART therapy or other ICS/LABA (medium and high dose) therapy and measure the efficacy for asthma control.
Detailed description
1. All not-well controlled asthma patients would include the study. 2. We will compare three ways of asthma control including SMART, fixed doses with regular doses and fixed doses with higher doses 3. We will evaluate the efficacy/safety for these not-well controlled patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Seretide | Using Symbicort and Seretide for asthma control measurements Compared with efficacy and safety |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-02-01
- Completion
- 2012-03-01
- First posted
- 2012-07-23
- Last updated
- 2012-07-24
Source: ClinicalTrials.gov record NCT01647646. Inclusion in this directory is not an endorsement.